Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

Abstract Background Aldosterone is elevated in chronic kidney disease (CKD) and may be involved in hypertension. Surprisingly, the determinants of the plasma aldosterone concentration (PAC) and its role in hypertension are not well studied in CKD. Therefore, we studied the determinants of aldosteron...

Full description

Bibliographic Details
Main Authors: Christina M. Gant, Gozewijn D. Laverman, Liffert Vogt, Maartje C. J. Slagman, Hiddo J. L. Heerspink, Femke Waanders, Marc H. Hemmelder, Gerjan Navis, Holland Nephrology Study (HONEST) Network
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Nephrology
Subjects:
Aldosterone
Chronic kidney disease
Creatinine clearance
RAAS inhibition
Systolic blood pressure
Dietary sodium restriction
Online Access:http://link.springer.com/article/10.1186/s12882-017-0789-x

Internet

http://link.springer.com/article/10.1186/s12882-017-0789-x

Similar Items